Status:
COMPLETED
Oxytocin for Oxidative Stress and Inflammation
Lead Sponsor:
Florida Institute for Human and Machine Cognition
Collaborating Sponsors:
Office of Naval Research (ONR)
University of Florida
Conditions:
Oxidative Stress
Inflammation
Eligibility:
MALE
18-39 years
Phase:
PHASE2
Brief Summary
Naval Special Warfare (NSW) operators are exposed to a variety of extreme environmental conditions and intense physical demands. In addition to breathing high pressure gases at depth, prolonged cold w...
Detailed Description
Naval Special Warfare (NSW) operators are exposed to a variety of extreme environmental conditions and intense physical demands. In addition to breathing high pressure and hyperoxic gases at depth, pr...
Eligibility Criteria
Inclusion
- Apparently healthy (assessed via health, activity, and medical history)
- BMI \< 30
- No chronic conditions that would preclude participation
- Recreationally skilled swimmer capable of a continuous 30 min kickboard swim
Exclusion
- \- Regular smoking. The smoking exclusion includes all forms (cigarettes, vaping, etc) due to well-established effects on lung function and systemic oxidative stress and inflammation
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04732247
Start Date
February 1 2022
End Date
September 15 2023
Last Update
February 22 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Translational Genomics Research Institute
Phoenix, Arizona, United States, 85004
2
University of Florida
Gainesville, Florida, United States, 32611
3
Florida Institute for Human and Machine Cognition
Pensacola, Florida, United States, 32502